6dfx: Difference between revisions

No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 6dfx is ON HOLD  until Paper Publication
==human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide==
<StructureSection load='6dfx' size='340' side='right'caption='[[6dfx]], [[Resolution|resolution]] 2.03&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6dfx]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6DFX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6DFX FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.03&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6dfx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6dfx OCA], [https://pdbe.org/6dfx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6dfx RCSB], [https://www.ebi.ac.uk/pdbsum/6dfx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6dfx ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/Q30069_HUMAN Q30069_HUMAN]
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
In type 1 diabetes (T1D), proinsulin is a major autoantigen and the insulin B:9-23 peptide contains epitopes for CD4(+) T cells in both mice and humans. This peptide requires carboxyl-terminal mutations for uniform binding in the proper position within the mouse IA(g7) or human DQ8 major histocompatibility complex (MHC) class II (MHCII) peptide grooves and for strong CD4(+) T cell stimulation. Here, we present crystal structures showing how these mutations control CD4(+) T cell receptor (TCR) binding to these MHCII-peptide complexes. Our data reveal stricking similarities between mouse and human CD4(+) TCRs in their interactions with these ligands. We also show how fusions between fragments of B:9-23 and of proinsulin C-peptide create chimeric peptides with activities as strong or stronger than the mutated insulin peptides. We propose transpeptidation in the lysosome as a mechanism that could accomplish these fusions in vivo, similar to the creation of fused peptide epitopes for MHCI presentation shown to occur by transpeptidation in the proteasome. Were this mechanism limited to the pancreas and absent in the thymus, it could provide an explanation for how diabetogenic T cells escape negative selection during development but find their modified target antigens in the pancreas to cause T1D.


Authors: Wang, Y., Dai, S.
How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.,Wang Y, Sosinowski T, Novikov A, Crawford F, White J, Jin N, Liu Z, Zou J, Neau D, Davidson HW, Nakayama M, Kwok WW, Gapin L, Marrack P, Kappler JW, Dai S Sci Immunol. 2019 Apr 5;4(34). pii: 4/34/eaav7517. doi:, 10.1126/sciimmunol.aav7517. PMID:30952805<ref>PMID:30952805</ref>


Description: human diabetogenic TCR T1D3 in complex with DQ8-p8E9E peptide
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Dai, S]]
<div class="pdbe-citations 6dfx" style="background-color:#fffaf0;"></div>
[[Category: Wang, Y]]
 
==See Also==
*[[MHC 3D structures|MHC 3D structures]]
*[[MHC II 3D structures|MHC II 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Dai S]]
[[Category: Wang Y]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA